Osteoporosis Drug Shows Great Promise

Osteoporosis is a silent disease that haunts millions of women in America.

Now, a drug patented by a researcher at the University of Pittsburgh School of Medicine is showing great promise.

Unlike drugs like Fosamax and Boniva – this treatment actually builds bone – and much more quickly than other treatment options.

Peg Fischer loves to play golf and Elise Fraser teaches pre-schoolers. But both ladies have osteoporosis.

The silent disease impacts millions of women in the United States – and at least 80 percent of those women are never diagnosed with the condition, which leads to a loss of strength in bones.

“Most women who have osteoporosis – if they haven’t had a bone density – don’t know it,” says Dr. Mara Horwitz, of the Pitt School of Medicine. “It is silent. It does not have any scientific symptoms until a fracture occurs.”

Horwitz adds that 70 percent of compression fractures in women with osteoporosis are painless.

“Women don’t realize that they have a fracture until they have had enough over time that they realize that all the sudden their pants are too long or they go to their doctor for their annual exam and they realize they’ve lost an inch or two in height,” said Dr. Horwitz.

A team of researchers led by Horwitz at the Pitt School of Medicine is conducting a study of a drug called para-thyroid hormone related peptide or PTHRP.

Early results show it helps post-menopausal women build bone and thereby fight fractures. The drug has shown that women have a five percent increase in bone density in the lumbar spine in just 90 days – something that would take as long as a year with current treatments.

Fischer has already completed her portion of the study.

“I feel stronger. I feel better,” she said. “Now this might all be psychological, but once they took the final DEX scan I thought, well, I have some improvement. Hope springs eternal.”

Fischer will finish on Nov. 8. Like all the participants in the study, she received a free bone scan that confirmed osteoporosis by showing a loss of bone density in the spine, hip or wrist.

All participants in the study give themselves daily injections of the drug. Fraser has already seen a bit more pep in her step.

“Now I found out I do have this weakness in my bones, and I was able to get the treatment, and thanks to the program, the treatment that I got is excellent. It’s one of the best treatments you can get,” she said

Scientists are a long way from declaring victory in the war on osteoporosis.

But Horwitz says, “We definitely are making headway in the people who are in treatment; unfortunately, a majority of people with osteoporosis still go undiagnosed and untreated. So we have many, many millions more women to diagnose and treat before we can say that we’ve got the majority of this disease under control.”

Researchers at Pitt are looking for post-menopausal women to participate in a study on osteoporosis.

Women selected for the study must not currently be on treatment for the condition that results in bone loss. All participants will receive a free bone scan from the research team.

If you are interested in learning more about the study, please call 800-872-3653.

The cutting-edge bone research being done here in Pittsburgh provides hope that a cure for osteoporosis could be right around the corner.

  • http://drugaddiction.treatments101.com/new-drug-research-incidence-rates-and-popes-comments-brighten-aids-outlook.html New drug research, incidence rates and Pope’s comments brighten AIDS outlook | Drug Addiction Treatments

    […] 25. Nov, 2010 0 Comments May 18, 2010 – Judge Peggy Hora’s talk on Drug Treatment Courts in the 21st Century Image by US Embassy New Zealand Drug treatment courts are an excellent example of a successful deviation from established practice. They were created by sitting criminal court judges, overwhelmed and appalled by the real world they saw before them each day. Not only do drug treatment courts introduce new concepts and practices to the legal community, but they do so while protecting the defendant’s procedural and substantive rights. Judge Peggy Hora retired from the California Superior Court after serving 21 years. She had a criminal assignment that included presiding over the Drug Treatment Court. She is a former dean of the B.E. Witkin Judicial College of California and has been on the faculty of the National Judicial College over 15 years. She is a recipient of the Bernard S. Jefferson Judicial Education Award from the California Judges’ Association and winner of the Rose Bird Award from California Women Lawyers. Judge Hora is a Senior Judicial Fellow for the National Drug Court Institute. She has lectured nationally and internationally and has written extensively on justice issues. The appellate court and over 100 journals and law reviews have cited her work. She is a 2009 Thinker in Residence appointed by the Premier of South Australia, where she is currently working on therapeutic jurisprudence and restorative justice issues for the government in Adelaide. Her most recent article, “Courting New Solutions Using Problem-Solving Justice: Key Components, Guiding Principles, Strategies, Responses, Models, Approaches, Blueprints and Tool Kits” will be published by the Chapman Law Review this spring. newzealand.usembassy.gov research of new drugs, the incidence rates and the Pope’s comments illuminate the perspectives AIDS The Associated Press. “In the nearly 30 years, the AIDS epidemic has raged, there has never been a hopeful day that three major events took place on Tuesday. UN officials said the new HIV cases are declining drastically throughout the World One study showed that a pill every day and on the shelves of the pharmacy may help prevent new infections in gay men. And the pope opened the way for the use of … Read more on News-Medical-Net UCLA researchers discover cancer resistance mechanisms in the most common form of melanoma Researchers at UCLA’s Jonsson Comprehensive Cancer Center have found that melanoma patients whose cancers are caused by mutation of the BRAF gene become resistant to a targeted treatment promising by another genetic mutation or overexpression of a protein the cell surface, driving the survival of cancer and accounts for relapse. The study, published in November .. Read more on Medical News Today Vertex seeks speedy approval of drugs Fifteen years after he began to develop a treatment for hepatitis C around which is being built is a business, Vertex Pharmaceuticals Inc. yesterday sought approval to sell the drug – the presentation of approximately one million pages. Read more on Boston Globe Osteoporosis Drug Shows Great Promise Osteoporosis is a silent disease that haunts millions of women in the United States. Now, a drug patented by a researcher at the University of Pittsburgh School of Medicine is a great promise. Unlike drugs such as Fosamax […] Read more on KDKA Pittsburgh […]

  • L M Lisi

    Yes, I am interested. Pls send further info. Tks much. L M Lisi

  • http://disease.gk3.de/osteoporosis-drug-shows-great-promise Osteoporosis Drug Shows Great Promise

    […] Read more on KDKA Pittsburgh […]

blog comments powered by Disqus
Bringing You The Best in Sports Talk Radio
Download And Win Today!

Listen Live